Multimodal Imaging Technology Effectively Monitors HER2 Expression in Tumors Using Trastuzumab-Coupled Organic Nanoparticles in Patient-Derived Xenograft Mice Models
Trastuzumab is a monoclonal antibody targeting human epidermal growth factor 2 (HER2), which has been successfully used in the treatment of patients with breast cancer and gastric cancer; however, problems concerning its cardiotoxicity, drug resistance, and unpredictable efficacy still remain. Herei...
Guardado en:
Autores principales: | Li Wen, Lei Xia, Xiaoyi Guo, Hai-Feng Huang, Feng Wang, Xian-teng Yang, Zhi Yang, Hua Zhu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c5ebd269418a4283b83e09e44815b3ff |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Imaging of Gastric Carcinomatosis
por: Raquel Saiz Martínez, et al.
Publicado: (2021) -
The Value of 18F-FDG PET/CT and Abdominal PET/MRI as a One-Stop Protocol in Patients With Potentially Resectable Colorectal Liver Metastases
por: Nina Zhou, et al.
Publicado: (2021) -
Role of Multimodal Imaging in Patients With Suspected Infections After the Bentall Procedure
por: Martina Sollini, et al.
Publicado: (2021) -
Delayed FDG PET Provides Superior Glioblastoma Conspicuity Compared to Conventional Image Timing
por: Jason Michael Johnson, et al.
Publicado: (2021) -
New probe for the improvement of the Spatial Resolution in total-body PET (PROScRiPT)
por: Ros A., et al.
Publicado: (2021)